New Capsule Now Implemented in Ongoing RA Study; AD Study Transition Planned Following the positive bioequivalence data, LAPIX has successfully transitioned patients in its Phase Ib RA study to the ...
The capsule demonstrated superior performance to the liquid formulation, achieving improved exposure while maintaining a favorable tolerability profile. These results support the capsule as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results